Selected article for: "admission hospital and serum albumin"

Author: Rizo-Téllez, Salma A.; Méndez-García, Lucia A.; Rivera-Rugeles, Ana C.; Miranda-García, Marcela; Manjarrez-Reyna, Aarón N.; Viurcos-Sanabria, Rebeca; Solleiro-Villavicencio, Helena; Becerril-Villanueva, Enrique; Carrillo-Ruíz, José D.; Cota-Arce, Julian M.; Álvarez-Lee, Angélica; De León-Nava, Marco A.; Escobedo, Galileo
Title: The Combined Use of Cytokine Serum Values with Laboratory Parameters Improves Mortality Prediction of COVID-19 Patients: The Interleukin-15-to-Albumin Ratio
  • Cord-id: zncur5v6
  • Document date: 2021_10_16
  • ID: zncur5v6
    Snippet: Laboratory parameters display limited accuracy in predicting mortality in coronavirus disease 2019 (COVID-19) patients, as with serum albumin. Emerging evidence suggests that cytokine serum values may enhance the predictive capacity of albumin, especially interleukin (IL)-15. We thus investigated whether the use of the IL-15-to-albumin ratio enables improving mortality prediction at hospital admission in a large group of COVID-19 patients. In this prospective cross-sectional study, we enrolled a
    Document: Laboratory parameters display limited accuracy in predicting mortality in coronavirus disease 2019 (COVID-19) patients, as with serum albumin. Emerging evidence suggests that cytokine serum values may enhance the predictive capacity of albumin, especially interleukin (IL)-15. We thus investigated whether the use of the IL-15-to-albumin ratio enables improving mortality prediction at hospital admission in a large group of COVID-19 patients. In this prospective cross-sectional study, we enrolled and followed up three hundred and seventy-eight patients with a COVID-19 diagnosis until hospital discharge or death. Two hundred and fifty-five patients survived, whereas one hundred and twenty-three died. Student’s T-test revealed that non-survivors had a significant two-fold increase in the IL-15-to-albumin ratio compared to survivors (167.3 ± 63.8 versus 74.2 ± 28.5), a difference that was more evident than that found for IL-15 or albumin separately. Likewise, mortality prediction considerably improved when using the IL-15-to-albumin ratio with a cut-off point > 105.4, exhibiting an area under the receiver operating characteristic curve of 0.841 (95% Confidence Interval, 0.725–0.922, p < 0.001). As we outlined here, this is the first study showing that combining IL-15 serum values with albumin improves mortality prediction in COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • absolute value and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • absolute value and liver function: 1
    • accuracy term and acute respiratory syndrome: 1, 2, 3
    • accurate mortality and acute ards respiratory distress syndrome: 1
    • accurate mortality and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • accurate mortality and liver disease: 1, 2, 3
    • acid metabolite and acute ards respiratory distress syndrome: 1
    • acid metabolite and acute respiratory syndrome: 1, 2, 3, 4
    • acid metabolite and liver function: 1
    • acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and adaptive innate immune cell: 1, 2
    • acute ards respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute ards respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and liver function test: 1, 2
    • acute ards respiratory distress syndrome and long duration: 1, 2, 3, 4
    • acute inflammatory disease and adaptive innate: 1, 2
    • acute inflammatory disease and liver disease: 1
    • acute respiratory syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and adaptive innate immune cell: 1, 2, 3, 4, 5, 6, 7